日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants.

鼻内给药广谱大环肽抑制剂可预防SARS-CoV-2 Omicron变异株感染。

Wang Min, Yang Jinyue, Tan Yahong, Yuan Shuofeng, Shi Guoli, Peng Qi, Li Yongqi, Poon Vincent Kwok-Man, Chan Chris Chung-Sing, Xiao Na, Zhang Anna Jinxia, Xie Yubin, Li Junhua, Luo Hao, Fu Yaning, Chen Yong, Compton Alex A, Zhang Youming, Yang Yang, Gao George Fu, Hou Hongwei, Chan Jasper Fuk-Woo, Yin Yizhen, Shi Yi

Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study

帕博利珠单抗、乐伐替尼和减量吉西他滨/奥沙利铂作为晚期胆道癌一线治疗的疗效和安全性:一项多中心、单臂、前瞻性 II 期研究

Piao, Mingjian; Li, Chengjie; Li, Shuofeng; Zhang, Nan; Li, Jiongyuan; Luo, Xu; Liu, Rong; Wang, Fei; Shi, Xiangde; Liu, Chao; Tan, Guang; Zhu, Zhenyu; Yang, Xiaobo; Zhao, Haitao

Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study

免疫检查点抑制剂治疗高微卫星不稳定性/错配修复缺陷型晚期胆管癌患者的疗效和安全性:一项倾向评分匹配研究

Piao, Mingjian; Yang, Xu; Li, Chengjie; Zhao, Jiayi; Zhang, Nan; Li, Jiongyuan; Huang, Ziyue; Li, Shuofeng; Sun, Boyu; Yang, Xiaobo; Zhao, Haitao

Local-regional therapy plus ICIs, chemotherapy, and lenvatinib versus ICIs plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter study

局部区域治疗联合免疫检查点抑制剂、化疗和乐伐替尼与免疫检查点抑制剂联合化疗治疗晚期肝内胆管癌的疗效比较:一项多中心研究

Wang, Mingming; Li, Shuofeng; Yu, Guanhua; Zhang, An; Ding, Shikang; Zhang, Yihong; Feng, Shi; Zhou, Zixiang; Piao, Mingjian; Pan, Weixuan; Li, Chengjie; Sun, Boyu; Li, Jiongyuan; Zhang, Nan; Chen, Xinyuan; Sun, Yongliang; Zhang, Wen; Zhu, Zhenyu; Zhao, Haitao

Molnupiravir is effective against hepatitis E virus infection in an animal model

在动物模型中,莫努匹拉韦对戊型肝炎病毒感染有效。

Wu, Shusheng; Chew, Nicholas Foo-Siong; Ma, Xiaodan; Situ, Jianwen; Shun, Estie Hon-Kiu; Li, Can; Ip, Jonathan Daniel; Ho, Siu-Fung Stanley; Zhang, Anna Jinxia; Tsoi, James Yiu-Hung; Chan, Wan-Mui; Ma, Weihui; Liang, Yonghao; Mao, Weiwei; Chen, Karina Wing Yee; Yin, Feifei; To, Kelvin Kai-Wang; Yuan, Shuofeng; Chan, Jasper Fuk-Woo; Zhu, Longchao; Huang, Yaowei; Sridhar, Siddharth

Comfort-Oriented Pothole Traversal Using Multi-Sensor Perception and Fuzzy Control

基于多传感器感知和模糊控制的舒适性坑洼路面穿越

Yuan, Chaochun; Hang, Shiqi; He, Youguo; Shen, Jie; Chen, Long; Cai, Yingfeng; Weng, Shuofeng; Wang, Junxian

The microbiome in cancer

癌症中的微生物组

Lin, Anqi; Xiong, Minying; Jiang, Aimin; Huang, Lihaoyun; Wong, Hank Z H; Feng, Suyin; Zhang, Chunyan; Li, Yu; Chen, Li; Chi, Hao; Zhang, Pengpeng; Ye, Bicheng; Zhang, Hengguo; Zhang, Nan; Zhu, Lingxuan; Mou, Weiming; Shen, Junyi; Li, Kailai; Xu, Wentao; Ying, Haoxuan; Zhang, Cangang; Zeng, Dongqiang; Xie, Jindong; Deng, Xinpei; Wang, Qi; Xu, Jianying; Shi, Wenjie; Qi, Chang; Qu, Chunrun; Huang, Xufeng; Hajdu, András; Li, Chaoqun; Peng, Changmin; Cao, Xuanye; Pei, Guangsheng; Zhang, Lin; Huo, Yujia; Xu, Jiabao; Glaviano, Antonino; Szöllősi, Attila Gábor; Bian, Sicheng; Li, Zhengrui; Tang, Hailin; Tang, Bufu; Liu, Zaoqu; Zhang, Jian; Miao, Kai; Cheng, Quan; Wei, Ting; Yuan, Shuofeng; Luo, Peng

iMeta Conference 2025: Creating high-impact international journals

2025年iMeta会议:创建高影响力国际期刊

Zhu, Zhihao; Zhang, Lin; Yao, Xiaofang; Zeng, Meiyin; Wang, Yao; Luo, Hao; Zhou, Yuanping; Zhang, Tianyuan; Xun, Jiani; Bai, Defeng; Yang, Haifei; Xu, Shanshan; Zhou, Yang; Gao, Yunyun; Xu, Jinbo; Han, Wei; Shen, ZiAng; Zhang, Bangzhou; Ma, Tengfei; Wan, Xiu-Lin; Ma, Chuang; Hui, Fengjiao; Bai, Hao; Bai, Lijing; Bai, Qing; Bao, Qiangguo; Cao, Guodong; Cao, Peng; Cao, Qiqi; Chen, Hu; Chen, Jiawen; Chen, Jiaxu; Chen, Lihua; Chen, Tingting; Chen, Yi; Cui, Haipeng; Dai, Shaoxing; Dai, Xi-Jian; Dai, Xiaofeng; Dang, Yanqi; Deng, Lei; Deng, Yun; Ding, Xia; Dong, Binhua; Dong, Ling; Dou, Shujie; Du, Hongzhi; Fang, Zhencheng; Feng, Xiaoxiao; Fu, Min; Gao, Yuan; Gong, Wenping; Guo, Xiang; Han, Wenjie; Hao, Zikai; He, Zheng-Guo; Hu, Haibo; Hu, Haiming; Hu, Xuefei; Huang, Liang; Huang, Xianya; Huang, Xueting; Hui, Haochen; Jia, Dingjiacheng; Jiang, Aimin; Jiang, Di; Jiang, Kun; Jiang, Dewei; Jin, Ying; Lai, Kunyang; Li, Chun; Li, Feng; Li, Fuyong; Li, Jing; Li, Juan; Li, Junling; Li, Kui; Li, Ling; Li, Moli; Li, Peiwu; Li, Peng; Li, Runze; Li, Shengnan; Li, Shujin; Li, Wanting; Li, Wenting; Li, Xiaojing; Li, Xinrui; Li, Xuemeng; Liang, Qiqi; Liao, Xiaoping; Liu, Boyang; Liu, Canzhao; Liu, Chang; Liu, Duanrui; Liu, Furong; Liu, Jianjun; Liu, Jinyao; Liu, Siqi; Liu, Tianyang; Liu, Wenjuan; Liu, Yan; Liu, Yang; Liu, Yi; Liu, Yuan; Liu, Yunhuan; Liu, Zhipeng; Liu, Zhiyong; Lu, Xin; Luo, Xiao; Ma, Guanju; Meng, Jialin; Meng, Yuanfa; Miao, Runyu; Miao, Linxuan; Ni, Yawen; Niu, Dongze; Niu, Tingting; Pan, Hongzhao; Qin, Guoqiang; Qiu, Tiantian; Qiu, Yueping; Qu, Hui; Qu, Linghang; Ren, Na; Sun, Qiang; Shang, Run; She, Peize; Shen, Xihui; Shi, Bohan; Shu, You; Song, Jiawei; Song, Weibin; Su, Qi; Sun, Qingzhu; Sun, YuPing; Sun, Zijin; Tang, Bufu; Tang, Deqin; Tang, Hua; Tao, Yongfu; Teng, Teng; Tu, Yanye; Wang, Cheng; Wang, Hui; Wang, Yunhao; Wang, Chunli; Wang, Dingjie; Wang, Gang; Wang, Jin; Wang, Kaiyi; Wang, Mingbang; Wang, Shan; Wang, Shixiang; Wang, Xiaojie; Wang, Xing-Chang; Wang, Yunzhe; Wang, Jiale; Wang, Zheng; Wang, Weijie; Wei, Yongjun; Xu, Wei; Wu, Fan; Wu, Junling; Wu, Shijuan; Xiao, Jian; Xiao, Weihua; Xiao, Yang; Xiong, Xi; Xiong, Xue; Xu, Feng; Xu, Junyu; Xu, Wen; Xu, Jun; Xu, Yao; Yan, Jun; Yao, Lutian; Yang, Jia; Yang, Lulu; Yang, Xingzhen; Yin, Naiyi; You, Hua; You, Min; Yu, Ting; Yu, Yongyao; Yu, Renqiang; Yuan, Shuofeng; Yue, Chaoxiong; Zeng, Xiaoya; Zha, Andong; Zhai, Leilei; Zhang, Chi; Zhang, Dong; Zhang, Hengguo; Zhang, Heng; Zhang, Hongyu; Zhang, Jiahao; Zhang, Jinyang; Zhang, Lishan; Zhang, Qi; Zhang, Xiang; Zhang, Xiangyu; Zhang, Xuelei; Zhang, Yancong; Zhang, Yuan; Zhang, Zhenyu; Zhao, Jiwei; Zhao, Jingxuan; Zhao, Kai; Zhao, Mingjuan; Zhao, Yi; Zhao, Yunxiang; Zhong, Jixin; Zhong, Ling; Zhong, Xiangjian; Zhou, Dan; Zhou, Wei; Zhou, Wen; Zhou, Yiqian; Zhou, Zhemin; Zhu, Shiquan; Liu, Shuang-Jiang; Feng, Suyin; Jin, Shuangxia; Xiao, Chuanxing; Wang, Ziheng; Luo, Peng; Chen, Tong; Chen, Gang; Liu, Yong-Xin

Author Correction: An orally available M(pro)/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo

作者更正:一种口服有效的M(pro)/TMPRSS2双特异性抑制剂在体内具有强大的抗冠状病毒功效

Shuai, Huiping; Qiao, Jingxin; Yoon, Chaemin; Zhang, Guo; Hou, Yuxin; Xia, Xiaoyan; Wang, Lei; Deng, Xinyue; Wang, Yifei; Li, Qingquan; Du, Lianzhao; Liu, Yuanchen; Zhou, Minmin; Wong, Hoi Ting; Hu, Jiaheng; Liu, Huan; Hu, Bingjie; Wang, Dong; Su, Jingyi; Pan, Yuying; Ye, Yongtao; Chen, Yan; Fang, Zhen; Xia, Ziyi; Chai, Yue; Shi, Jialu; Wang, Yang; Zhu, Tianrenzheng; Zhang, Honglei; Yuan, Shuofeng; Zhou, Jie; Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung; Xu, Chunfu; Lei, Jian; Yang, Shengyong; Chu, Hin

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

SARS-CoV-2 JN.1 衍生变体(包括 JN.1.7、KP.2、KP.3 和 KP.3.1.1)的致病性、病毒学特征和免疫逃避。

Shi Jialu, Zhao Xiaoyu, Jin Xiaohui, Li Jiayan, Liu Yuanchen, Liu Huan, Hu Ye-Fan, Chen Zhe, Xiao Yuxin, Wang Lei, Wang Yajie, He Yixin, Chai Yue, Hu Bingjie, Shuai Huiping, Wang Yang, Li Xiangnan, Jiang Shujun, Zhang Yanliang, Zhang Xiaojuan, Chan Wan-Mui, Chen Lin-Lei, Cai Jian-Piao, Sui Baokun, Zhang Honglei, Yang Dong, Zhu Longchao, Yuan Shuofeng, Zhou Jie, Huang Jian-Dong, Yuen Kwok-Yung, To Kelvin Kai-Wang, Chan Jasper Fuk-Woo, Zhang Bao-Zhong, Wang Qiao, He Maozhou, Sun Lei, Wang Pengfei, Chu Hin